Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of an oral testosterone
undecanoate formulation for use as testosterone-replacement therapy in men with low
testosterone.
Phase:
Phase 3
Details
Lead Sponsor:
Clarus Therapeutics, Inc.
Collaborators:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center PharmaNet